Glucose B.Braun

Glucose B.Braun is an intravenous solution for injection containing glucose as the sole active ingredient. It is supplied in a sterile liquid form without a specified concentration, intended for use in the European market. The product is administered by healthcare professionals to provide a source of energy directly into the bloodstream. It is commonly used in clinical settings for managing low blood sugar and supporting nutrition.

Glucose B.Braun is indicated for several clinical situations where rapid elevation of blood glucose or fluid replacement is required.

- Acute treatment of hypoglycemia to quickly raise blood glucose levels in both adult and pediatric patients. - Provision of a carbohydrate source as part of total parenteral nutrition solutions for patients unable to receive enteral feeding. - Adjunctive fluid therapy to replace volume and maintain hemodynamic stability during surgery or trauma care. - Support for patients undergoing prolonged fasting, such as before diagnostic procedures, to prevent hypoglycemia. - Facilitation of electrolyte balance when administered together with compatible salt solutions in intravenous therapy.

Glucose B.Braun may be associated with a range of adverse reactions, most of which are related to the intravenous administration of a carbohydrate solution.

Common: - Local irritation or pain at the injection site. - Mild hyperglycemia with transient elevation of blood glucose. - Nausea or vomiting, especially if administered rapidly. - Headache or light‑headedness. - Transient flushing or feeling of warmth during infusion. - Serious: - Severe hyperglycemia leading to osmotic diuresis or ketoacidosis in susceptible patients. - Allergic reactions such as urticaria, rash, or anaphylaxis. - Electrolyte disturbances (e.g., hypernatremia) when combined with inappropriate salt solutions. - Volume overload causing pulmonary edema in patients with compromised cardiac function. - Hypotension due to rapid infusion of large volumes. -

When using Glucose B.Braun, clinicians should observe several precautions to ensure safe administration and to minimize the risk of complications.

- Verify patient’s blood glucose level before and during infusion to avoid excessive hyperglycemia. - Adjust infusion rate according to individual tolerance and clinical condition. - Use compatible IV sets and avoid mixing with incompatible drugs or solutions. - Monitor fluid balance and electrolytes, especially in patients with renal or cardiac impairment. - Assess for signs of allergic reaction during the first administration. - Ensure aseptic technique to prevent contamination.

Glucose B.Braun can interact with other intravenous agents; awareness of potential interactions helps maintain therapeutic effectiveness and patient safety.

Avoid: - Co‑administration with high‑dose insulin infusions without close glucose monitoring. - Mixing with calcium‑containing solutions that may precipitate. - Concurrent use with hyperosmolar drugs that could exacerbate fluid overload. - Administering with potassium chloride solutions without proper dilution, as high glucose may affect potassium distribution.

Use with caution: - Concurrent administration with diuretics; monitor electrolytes and fluid status. - Use alongside beta‑blockers, as they may mask hypoglycemia symptoms. - Combination with other carbohydrate solutions; adjust total glucose load to prevent hyperglycemia. - Use in patients receiving corticosteroids, which can increase blood glucose levels; monitor closely.